NorthCoast Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

NorthCoast Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$543K	Buy	898 +5	+0.6%	+$3.1K	0.02%	339
2021 Q2	$499K	Buy	893 +3	+0.3%	+$1.52K	0.02%	332
2021 Q1	$421K	Sell	890 -5	-0.6%	-$2.43K	0.02%	325
2020 Q4	$432K	Sell	895 -124	-12%	-$66.9K	0.02%	274
2020 Q3	$570K	Sell	1,019 -164	-14%	-$99.4K	0.03%	239
2020 Q2	$738K	Sell	1,183 -62	-5%	-$35.2K	0.04%	195
2020 Q1	$608K	Buy	+1,245	New	+$514K	0.04%	199

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

NorthCoast Asset Management's REGN Position: Q3 2021 in Review

NorthCoast Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 0.56% in Q3 2021, buying an estimated $3.1K and bringing the position to 898 shares worth $543K. The position accounts for 0.02% of the portfolio, ranked #339.

NorthCoast Asset Management first reported a position in REGN in Q1 2020 and has held it in 7 quarters since. The position peaked at $738K in Q2 2020. 1,018 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

NorthCoast Asset Management held 898 shares of Regeneron Pharmaceuticals worth $543K as of Q3 2021.
NorthCoast Asset Management bought 5 Regeneron Pharmaceuticals shares in Q3 2021, an estimated $3.1K.
Regeneron Pharmaceuticals made up 0.02% of NorthCoast Asset Management's portfolio in Q3 2021, its #339 holding.
NorthCoast Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 7 quarters since.
NorthCoast Asset Management's Regeneron Pharmaceuticals position peaked at $738K in Q2 2020.
1,018 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.